ACRO Executive Director, Doug Peddicord, authored an Op-Ed for Morning Consult on the spotlight put on clinical trials during the pandemic, and
what it means for the future of the industry.
ACRO released a new analytical report on the takeaways from our 2020 landscape survey of RBM and RBQM implementation.
Click here for ACRO’s latest statements on the COVID-19 pandemic.
Read about ACRO’s initiatives, COVID-19 efforts, and more.
Take a look at how our members are innovating in top focus areas.
#COVID19 challenged the #healthcare industry. @IQVIA_global hosted a recent webinar on how the #pandemic impacted medication use and spending trends across the U.S. — and highlighted deficiencies across underserved populations. https://bit.ly/3QS99td
Andrew Barnhill, J.D., head of policy, Global Legal, reflects on his #career journey at #IQVIA through the lens of #PrideMonth. 🏳️🌈 Read more: https://bit.ly/3xTXouG #BraveAndProud #WeAreIQVIA @ATBarnhill
A recent Harris Poll showed that trust in the #pharmaceutical industry has dropped over the last year. @SyneosHealth explores what #LifeSciences organizations can do to boost and maintain the critical trust between themselves and the public. https://bit.ly/3Ajo2P8
Get ACRO’s newsletter to stay informed about our work and the industry.
Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…
Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…
The below is the Op-Ed authored by ACRO Executive Director, Doug Peddicord for Morning Consult on November 3, 2021. Read the full…
Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now…
Washington, DC — The Association of Clinical Research Organizations (ACRO) congratulates Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) on the release…
Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
';